Notes - Segment Information, Etc.

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7256444

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
JPY
1,788,614,000 JPY
182,592,000 JPY
7,789,462,000 JPY
2,345,105,000 JPY
7,789,462,000 JPY
3,473,148,000 JPY
174,185,000 JPY
JPY
3,393,447,000 JPY
7,738,426,000 JPY
1,718,102,000 JPY
7,738,426,000 JPY
2,452,690,000 JPY
Other items
Depreciation
JPY
64,653,000 JPY
32,544,000 JPY
430,343,000 JPY
121,579,000 JPY
430,343,000 JPY
211,566,000 JPY
32,508,000 JPY
JPY
211,076,000 JPY
411,587,000 JPY
52,332,000 JPY
411,587,000 JPY
115,669,000 JPY
Increase in property, plant and equipment and intangible assets
JPY
49,580,000 JPY
5,223,000 JPY
576,617,000 JPY
201,011,000 JPY
576,617,000 JPY
320,801,000 JPY
8,257,000 JPY
JPY
244,480,000 JPY
493,180,000 JPY
80,240,000 JPY
493,180,000 JPY
160,200,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.